Home » Stocks » PolyPid

PolyPid Ltd. (PYPD)

Stock Price: $13.55 USD 0.55 (4.23%)
Updated Sep 18, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 230.98M
Revenue (ttm) n/a
Net Income (ttm) 6.91M
Shares Out 17.05M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Sep 18, 2020
Last Price $13.55
Previous Close $13.00
Change ($) 0.55
Change (%) 4.23%
Day's Open 13.24
Day's Range 12.90 - 13.55
Day's Volume 9,000
52-Week Range 10.76 - 19.45

More Stats

Market Cap 230.98M
Enterprise Value 204.00M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 17.05M
Float n/a
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -32.42
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 151,670
Short Ratio 0.32
Short % of Float 0.07%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 2.72
Revenue n/a
Operating Income -18.56M
Net Income 6.91M
Free Cash Flow -18.24M
Net Cash 26.98M
Net Cash / Share 1.58
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC 45.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 4
Overweight 1
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(90.41% upside)
Current: $13.55
Target: 25.80
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-18.56-18.36
Net Income6.91-5.92
Shares Outstanding0.560.56
Earnings Per Share-23.69-0.86
Operating Cash Flow-17.36-16.68
Capital Expenditures-0.88-3.07
Free Cash Flow-18.24-19.75
Cash & Equivalents26.987.55
Net Cash / Debt26.987.55
Book Value-87.63-81.71
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name PolyPid Ltd.
Country Israel
Employees 57
CEO Amir Weisberg

Stock Information

Ticker Symbol PYPD
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: PYPD
IPO Date June 26, 2020


PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform. Its products include D-PLEX, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX100 for the prevention of post-abdominal surgery incisional infection; BONYPID-1000, an antibiotic eluting ß tri-calcium phosphate granule for bone related infections applications; and BONYPID?500, an antibiotic eluting bone graft substitute that fills and reconstructs periodontal and oral/maxillofacial defects, while protecting from infections. PolyPid Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel. Address: 18 Hasivim Street, Petach Tikva, Israel, 4959376